expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
Published 2 years ago • 1.3K plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
21:47
esmo daily reporter talk: the role of cdk4/6 inhibitors in the early stage of #breastcancer.
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:22
dr. rugo on resistance to cdk4/6 inhibitors in hr breast cancer
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
4:39
treatment following relapse on cdk4/6 inhibitors
-
23:44
park and graff explore the evolving role of cdk4/6 inhibitors in metastatic breast cancer
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
14:51
expert perspectives: targeting advanced er metastatic breast cancer with cdk 4/6 inhibitors
-
0:37
cdk4/6 inhibitors in her2-negative breast cancer based on phase iii monaleesa-7 trial
-
0:50
investigating mechanisms of resistance to cdk4/6 inhibitors
-
2:40
resistance to cdk4/6 inhibitors
-
8:55
cdk4/6 inhibitors in hr metastatic breast cancer
-
10:02
expert perspectives: cdk 4/6 inhibitors for er breast cancer: emerging data and future implications
-
8:42
hr mbc: treatment after progression on cdk4/6 inhibition
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer